Agilent Technologies, Inc. $A Shares Sold by UNIVEST FINANCIAL Corp

UNIVEST FINANCIAL Corp lessened its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 12.9% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 6,888 shares of the medical research company’s stock after selling 1,021 shares during the quarter. UNIVEST FINANCIAL Corp’s holdings in Agilent Technologies were worth $813,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of A. Brighton Jones LLC grew its holdings in Agilent Technologies by 6.1% during the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after buying an additional 270 shares during the last quarter. Vontobel Holding Ltd. grew its holdings in Agilent Technologies by 16.3% during the 1st quarter. Vontobel Holding Ltd. now owns 19,444 shares of the medical research company’s stock valued at $2,275,000 after buying an additional 2,730 shares during the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd grew its holdings in Agilent Technologies by 1.7% during the 1st quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 38,461 shares of the medical research company’s stock valued at $4,499,000 after buying an additional 661 shares during the last quarter. DAVENPORT & Co LLC grew its holdings in Agilent Technologies by 14.9% during the 1st quarter. DAVENPORT & Co LLC now owns 9,394 shares of the medical research company’s stock valued at $1,099,000 after buying an additional 1,217 shares during the last quarter. Finally, Novem Group grew its holdings in Agilent Technologies by 30.2% during the 1st quarter. Novem Group now owns 8,053 shares of the medical research company’s stock valued at $942,000 after buying an additional 1,866 shares during the last quarter.

Agilent Technologies Trading Up 0.1%

Shares of A opened at $143.28 on Friday. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The firm has a market capitalization of $40.62 billion, a P/E ratio of 33.63, a price-to-earnings-growth ratio of 4.67 and a beta of 1.26. The stock’s fifty day simple moving average is $132.48 and its 200 day simple moving average is $120.47. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $153.84.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting the consensus estimate of $1.37. The business had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The business’s quarterly revenue was up 10.1% on a year-over-year basis. During the same period last year, the company posted $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, equities research analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th were given a $0.248 dividend. This represents a $0.99 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 30th. Agilent Technologies’s dividend payout ratio (DPR) is 23.24%.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on A shares. UBS Group upgraded Agilent Technologies from a “neutral” rating to a “buy” rating and increased their target price for the company from $130.00 to $170.00 in a report on Wednesday, October 8th. Weiss Ratings restated a “hold (c)” rating on shares of Agilent Technologies in a report on Wednesday, October 8th. Evercore ISI raised their price objective on Agilent Technologies from $128.00 to $140.00 and gave the stock an “in-line” rating in a report on Tuesday, October 7th. Barclays raised their price objective on Agilent Technologies from $125.00 to $150.00 and gave the stock an “equal weight” rating in a report on Thursday, October 2nd. Finally, Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Friday, October 3rd. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $149.62.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.